Passage Bio Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Passage Bio stock has a consensus rating of "Hold" and an average price target of $12. The average 1-year stock price forecast is 103.56% higher than the current stock price, while the lowest is $7.00 (+18.74%) and the highest is $23 (+290.16%).

Price Target: $12 (+103.56%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$7.00	$12	$9.00	$23
Change	+18.74%	+103.56%	+52.67%	+290.16%

* Price targets were last updated on Apr 21, 2026.

Analyst Ratings

The average analyst rating for Passage Bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	6	6	6	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brendan Smith TD Cowen	TD Cowen	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 12, 2026
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Buy Maintains $23	Buy	Maintains	$23	+290.16%	Apr 21, 2026
Janani Sundararajan Chardan Capital	Chardan Capital	Hold Downgrades $7	Hold	Downgrades	$7	+18.74%	Apr 21, 2026
Yun Zhong Wedbush	Wedbush	Hold Downgrades $32 → $8	Hold	Downgrades	$32 → $8	+35.71%	Apr 20, 2026
Elemer Piros Lucid Capital	Lucid Capital	Hold Downgrades $68 → $9	Hold	Downgrades	$68 → $9	+52.67%	Apr 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-9.21

from -14.35

EPS Next Year

-7.84

from -9.21

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-177.73M	-129.29M	-103.00M	-65.17M	-43.15M	-38.97M
Net Income	-185.39M	-136.13M	-102.06M	-64.77M	-45.52M	-36.51M
EPS	-69.51	-50.02	-37.29	-21.04	-14.35	-9.21
Free Cash Flow	-91.09M	-76.01M	-48.22M	-27.55M	-18.80M	-37.50M
No. Analysts	-	-	-	-	-	5

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-4.87
Avg	-9.21
Low	-14.08

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.